ESCMID Global 2026
-
healthAI Offers New Hope in Global Fight Against Antimicrobial Resistance
Experts urge responsible AI integration to combat the growing AMR crisis, enhancing antimicrobial stewardship and patient care in hospitals worldwide.
-
healthWHO Antibiotic Guidelines Ineffective for Neonatal Sepsis in LMICs
New study reveals WHO-recommended first-line antibiotics are effective in only 25% of neonatal sepsis cases in low- and middle-income countries, highlighting critical antimicrobial resistance.
-
healthAntibiotic Resistance Genes Found in Newborns Within Hours of Birth
Study presented at ESCMID Global 2026 reveals antibiotic resistance genes in newborns shortly after birth, highlighting concerns for neonatal care and infection control.
-
healthART Therapy Reverses Biological Aging in HIV Patients
A Swiss study presented at ESCMID Global 2026 reveals antiretroviral therapy reduces biological aging in HIV patients by nearly 4 years, offering new insights into treatment implications.
-
healthCerebral Malaria Linked to Lasting Cognitive Deficits in Young Children
New research presented at ESCMID Global 2026 reveals cerebral malaria and severe malarial anemia cause long-term cognitive impairment in children under five.
-
healthMaternal RSV Vaccine Slashes Infant Hospitalizations Over 80%
New UK study reveals maternal RSV vaccination significantly cuts infant hospitalizations, especially when given weeks before birth. Important findings for preterm infants.